AED manufacturer switching — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Lamotrigine is a Category 1 anti-epileptic and the same manufacturer's product should be maintained where possible
The MHRA classifies anti-epileptic drugs into three categories based on the clinical significance of switching between different manufacturers' products. Lamotrigine is Category 1, meaning the same manufacturer's product should be dispensed consistently to avoid variability in plasma levels and potential loss of seizure control. If a switch is unavoidable, increased clinical monitoring is recommended.
Reference: MHRA Drug Safety Update; BNF